Stockreport

ImmunityBio to Showcase Advances for Bladder and Prostate Cancer at American Urological Association (AUA) Annual Meeting [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF bladder cancer carcinoma in situ (NMIBC CIS) with or without Ta/T1 papillary disease and papillary disease alone ImmunityBio to present keynote events on NMIBC and exp [Read more]